Susquehanna International Group’s CureVac CVAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-23,604
| Closed | -$107K | – | 13304 |
|
|
2025
Q4 | $107K | Sell |
23,604
-6,655
| -22% | -$34.1K | ﹤0.01% | 11417 |
|
|
2025
Q3 | $163K | Buy |
+30,259
| New | +$164K | ﹤0.01% | 11201 |
|
|
2025
Q2 | – | Sell |
-94,707
| Closed | -$376K | – | 12794 |
|
|
2025
Q1 | $262K | Sell |
94,707
-3,144
| -3% | -$10.9K | ﹤0.01% | 10366 |
|
|
2024
Q4 | $334K | Buy |
97,851
+12,527
| +15% | +$36.1K | ﹤0.01% | 9590 |
|
|
2024
Q3 | $251K | Sell |
85,324
-65,309
| -43% | -$215K | ﹤0.01% | 10003 |
|
|
2024
Q2 | $512K | Buy |
150,633
+24,326
| +19% | +$79.6K | ﹤0.01% | 8212 |
|
|
2024
Q1 | $383K | Sell |
126,307
-51,865
| -29% | -$182K | ﹤0.01% | 9131 |
|
|
2023
Q4 | $750K | Sell |
178,172
-45,201
| -20% | -$245K | ﹤0.01% | 7694 |
|
|
2023
Q3 | $1.53M | Sell |
223,373
-157,626
| -41% | -$1.39M | ﹤0.01% | 5699 |
|
|
2023
Q2 | $3.97M | Buy |
380,999
+259,910
| +215% | +$2.32M | ﹤0.01% | 3900 |
|
|
2023
Q1 | $844K | Buy |
+121,089
| New | +$1.06M | ﹤0.01% | 7264 |
|
|
2022
Q4 | – | Sell |
-105,001
| Closed | -$776K | – | 12605 |
|
|
2022
Q3 | $827K | Sell |
105,001
-70,346
| -40% | -$820K | ﹤0.01% | 7129 |
|
|
2022
Q2 | $2.39M | Sell |
175,347
-111,322
| -39% | -$1.84M | ﹤0.01% | 4537 |
|
|
2022
Q1 | $5.62M | Buy |
286,669
+33,636
| +13% | +$672K | ﹤0.01% | 3440 |
|
|
2021
Q4 | $8.68M | Buy |
253,033
+17,529
| +7% | +$705K | ﹤0.01% | 2922 |
|
|
2021
Q3 | $12.9M | Buy |
235,504
+135,405
| +135% | +$8.16M | ﹤0.01% | 2527 |
|
|
2021
Q2 | $7.36M | Sell |
100,099
-215,939
| -68% | -$21.6M | ﹤0.01% | 3357 |
|
|
2021
Q1 | $28.9M | Buy |
316,038
+194,291
| +160% | +$18.8M | ﹤0.01% | 1508 |
|
|
2020
Q4 | $9.87M | Sell |
121,747
-3,789
| -3% | -$290K | ﹤0.01% | 2509 |
|
|
2020
Q3 | $5.84M | Buy |
+125,536
| New | +$7M | ﹤0.01% | 2856 |
|
Susquehanna International Group's CVAC Position: Q1 2026 in Review
Susquehanna International Group sold out of CureVac (CVAC) in Q1 2026, closing a stake of 23,604 shares — an estimated $107K sold.
Susquehanna International Group first reported a position in CVAC in Q3 2020 and held it in 20 quarters. The position peaked at $28.9M in Q1 2021. 0 funds tracked by Wall St. Rank hold CVAC as of Q1 2026.
- Susquehanna International Group reported no remaining CureVac position as of Q1 2026 after selling out during the quarter.
- Susquehanna International Group sold 23,604 CureVac shares in Q1 2026, an estimated $107K.
- Susquehanna International Group first reported a position in CureVac in Q3 2020 and held it in 20 quarters.
- Susquehanna International Group's CureVac position peaked at $28.9M in Q1 2021.
- 0 funds tracked by Wall St. Rank held CureVac as of Q1 2026.
Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.